AstraZeneca PLC
AZN Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of AZN by members of U.S. Congress
AZN Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
AZN Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
AZN Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AZN's directors and management
Government lobbying spending instances
-
$1,240,000 Apr 21, 2025 Issue: Health Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark
-
$640,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid Pharmacy Taxation/Internal Revenue Code Copyright/Patent/Trademark Insurance
-
$650,000 Oct 21, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
-
$950,000 Jul 22, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
-
$700,000 Apr 22, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
-
$80,000 Feb 07, 2024 Issue: Health Issues Medicare/Medicaid Pharmacy Budget/Appropriations
-
$830,000 Jan 22, 2024 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
-
$950,000 Oct 20, 2023 Issue: Copyright/Patent/Trademark Taxation/Internal Revenue Code Pharmacy Medicare/Medicaid Health Issues
Estimated quarterly lobbying spending
AZN Revenue by Segment or Geography
By Segment
By Geography
AZN Income Statement
AZN Balance Sheet
AZN Cash Flow
U.S. Patents
New patents grants
-
Patent Title: Maleate salts of a quinazoline derivative useful as an antiangiogenic agent Oct. 14, 2014
-
Patent Title: Pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy Oct. 14, 2014
-
Patent Title: Inhibitors of protein kinases Sep. 23, 2014
-
Patent Title: Pyrazolylaminopyridine derivatives useful as kinase inhibitors Sep. 16, 2014
-
Patent Title: Process for preparing dipeptidyl peptidase iv inhibitors and intermediates therefor Aug. 19, 2014
-
Patent Title: Crystal forms of saxagliptin and processes for preparing same Aug. 12, 2014
-
Patent Title: Inhaler 624 Aug. 12, 2014
-
Patent Title: Method for treating hyperuricemia employing an sglt2 inhibitor and composition containing same Jul. 29, 2014
-
Patent Title: Pyrimidline derivatives having immune modulating properties that act via tlr7 for the treatment of viral or allergic diseases and cancers Jul. 01, 2014
-
Patent Title: Process for the manufacture of 4-fluoro-2-methyl-1h-indol-5-ol Jun. 17, 2014
-
Patent Title: Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6-{[(1r,2s)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide Jun. 10, 2014
-
Patent Title: Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors Jun. 03, 2014
-
Patent Title: Benzamide compounds useful as histone deacetylase inhibitors May. 27, 2014
-
Patent Title: Compound May. 27, 2014
-
Patent Title: Quinazoline derivatives as tyrosine kinase inhibitors May. 27, 2014
-
Patent Title: Pyrimidine sulphonamide derivatives as chemokine receptor modulators May. 13, 2014
-
Patent Title: Biphenyloxyacetic acid derivatives for the treatment of respiratory disease May. 13, 2014
-
Patent Title: Heterocyclic compounds as ccr2b antagonists Apr. 29, 2014
-
Patent Title: Compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation Apr. 15, 2014
-
Patent Title: Therapeutic agents Apr. 01, 2014
-
Patent Title: Combination product comprising src kinase inhibitor azdo530 and an antioestrogen or egfr-tk-inhibitor Mar. 25, 2014
-
Patent Title: Chemical compounds Mar. 18, 2014
-
Patent Title: Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9h-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy Mar. 18, 2014
-
Patent Title: Chromenone derivatives Mar. 18, 2014
-
Patent Title: Dental implant Mar. 11, 2014
-
Patent Title: Process for the preparation of crystalline modifications for use in the preparation of esomeperazole sodium salt Feb. 25, 2014
-
Patent Title: Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections Feb. 25, 2014
-
Patent Title: Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits Feb. 18, 2014
-
Patent Title: Dibenzothiazepine derivatives and uses thereof—424 Feb. 18, 2014
-
Patent Title: Quinazoline derivatives as vegf inhibitors Feb. 04, 2014
-
Patent Title: Compounds Jan. 14, 2014
-
Patent Title: Inhalation device and a method for assembling said inhalation device Dec. 31, 2013
-
Patent Title: N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof Dec. 10, 2013
-
Patent Title: Inhalation device Nov. 19, 2013
-
Patent Title: Entraining powder in an airflow Nov. 12, 2013
-
Patent Title: 9-substituted 8-oxoadenine compound Nov. 05, 2013
-
Patent Title: Composition for inhalation Nov. 05, 2013
-
Patent Title: Heterocyclic urea derivatives and methods of use thereof Oct. 29, 2013
-
Patent Title: Pyridine compounds Oct. 29, 2013
-
Patent Title: Process for preparing [1 Oct. 22, 2013
-
Patent Title: Chemical compounds Oct. 08, 2013
-
Patent Title: (3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compounds Oct. 01, 2013
-
Patent Title: Chromenone derivatives Sep. 10, 2013
-
Patent Title: Inhaler device that reduces the risk for miscounting a dosage Sep. 10, 2013
-
Patent Title: Phenoxyacetic acid derivatives useful for treating respiratory diseases Sep. 03, 2013
-
Patent Title: Bi-aryl amide compounds as crth2 receptor modulators Aug. 13, 2013
-
Patent Title: 2-pyridone derivatives as neutrophil elastase inhibitors and their use Aug. 06, 2013
-
Patent Title: Quinazoline derivatives as angiogenesis inhibitors Jul. 23, 2013
-
Patent Title: Elastic surgical ring clip/loader and a method Jul. 23, 2013
-
Patent Title: 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyrazol-3-yl) -3h-imidazo[4,5-b] pyridin-5-amine derivatives and their use for the treatment of cancer Jul. 16, 2013
Government Contracts
Federal grants, loans, and purchases
- $1,810 2024-12-30 00:00:00 Agency: Department of Health and Human Services
- $2,076 2024-12-30 00:00:00 Agency: Department of Health and Human Services
- $0 2024-04-24 00:00:00 Agency: Department of Veterans Affairs
- $2,023 2024-01-02 00:00:00 Agency: Department of Health and Human Services
- $1,764 2024-01-02 00:00:00 Agency: Department of Health and Human Services
- $20,322 2023-07-27 00:00:00 Agency: Department of Health and Human Services
Government Contracts
Estimated quarterly amount awarded from public contracts
AZN News
Recent insights relating to AZN
CNBC Recommendations
Recent picks made for AZN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in AZN
AZN Analyst Ratings
AZN Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
AZN Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $AZN stock a Buy, Sell, or Hold?
- What is the price target for $AZN stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
AZN Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $AZN stock?
- Who owns the most shares of $AZN stock?
- What funds own $AZN stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
AZN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view AZN Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More